Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus

Journal of Clinical Rheumatology

Volumn 12, Issue 1, 2006, Pages 3-10

  Roldan, Carlos A ^a,b   Gelgand, Erika A ^a   Qualls, Clifford R ^a   Sibbitt Jr , Wilmer L ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b VA Medical Center   (United States)

Author keywords

Magnetic resonance imaging; Neuropsychiatric systemic lupus erythematosus; Systemic lupus erythematosus; Transesophageal echocardiography; Valvular heart disease

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOPHOSPHAMIDE; PREDNISONE; WARFARIN;

ACUTE CONFUSION; ADULT; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MENTAL DISEASE; MITRAL VALVE DISEASE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; ADOLESCENT; BRAIN VASCULITIS; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; MIDDLE AGED; NONPARAMETRIC TEST; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART VALVE DISEASES; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 33745924135     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000200378.42836.7f     Document Type: Article

References (38)

1. Hanly JG, McCurdy G, Fougere L, et al. Neuropsychiatric events in systemic lupus erythematosus. Attribution and clinical significance. J Rheumatol. 2004;31:2156-2162.
2. Abu-Shakra M, Urowitz MB, Gladmann DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death. J Rheumatol. 1995;22:1259-1264.
3. Fiallo P, Tomasina C, Clapasson A, et al. Antibodies to beta (2)-glycoprotein I in ischemic stroke. Cerebrovasc Dis. 2000;10:293-297.
4. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2399-2406.
5. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. A clinical-pathological study of 24 cases and review of the literature. Medicine. 1968;47:337-369.
6. Sibbitt WL Jr, Sibbitt RR, Griffey RH, et al. Magnetic resonance and CT imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis. 1989;48:1014-1022.
7. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum. 1979;8:212-221.
8. Ellison D, Gatter K, Heryet A, et al. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol. 1993;46:37-40.
9. Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol. 1992;20:1127-1134.
10. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424-1430.
11. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701-737.
12. Roldan CA, Gelgand EA, Qualls CR, et al. Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol. 2005;95:1441-1447.
13. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;41:599-608.
14. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 1992;35:630-640.
15. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39:363-369.
16. Sibbitt WL Jr, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Rev Arthritis Rheum. 1999;42:2026-2038.
17. Sibbitt WL Jr, Schmidt PJ, Hart BL, et al. Fluid attenuated inversion recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus. J Rheumatol. 2003;30:1983-1989.
18. Crawford MH, Roldan CA. Quantitative assessment of valve thickness in normal subjects by transesophageal echocardiography. 2001;87:1419-1423.
19. Enriquez-Sarano M, Miller FA Jr, Hayes SN, et al. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol. 1995;25:703-709.
20. Heinle SK, Hall SA, Brickner ME, et al. Comparison of vena contracta width by transesophageal echocardiography with quantitative Doppler assessment of mitral regurgitation. Am J Cardiol. 1998;81:175-179.
21. Tribouilloy CM, Enriquez-Sarano M, Fett SL, et al. Application of the proximal flow convergence method to calculate the effective regurgitant orifice area in aortic regurgitation. J Am Coll Cardiol. 1998;32:1032-1039.
22. Tribouilloy CM, Enriquez-Sarano M, Bailey KR, et al. Assessment of severity of aortic regurgitation using the width of the vena contracta: a clinical color Doppler imaging study. Circulation. 2000;102:558-564.
23. Sibbitt WL Jr, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29:1536-1542.
24. Hachulla E, Michon-Pasturel U, Leys D, et al. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus. 1998;7:124-131.
25. Sabet A, Sibbitt WL Jr, Stidley CA, et al. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke. 1998;29:2254-2260.
26. Sibbitt WL Jr, Sibbitt RR. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin N Am. 1993;19:851-868.
27. Stimmler MM, Coletti PM, Quismorio FP Jr. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum. 1993;22:335-349.
28. Senecal JL, Raymond Y. The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease? J Rheumatol. 2004;31:2093-2098.
29. Morelli S, Bernardo ML, Viganego F, et al. Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus. Lupus. 2003;12:805-812.
30. Barbut D, Borer JS, Wallerson D, et al. Anticardiolipin antibody and stroke: possible relation of valvular heart disease and embolic events. Cardiology. 1991;79:99-109.
31. Cardiology. 1992;80:156-158.
32. Pope JM, Canny CL, Bell DA. Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant. Am J Med. 1991;90:299-309.
33. Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke. 1989;20:583-591.
34. Stroke. 1990;21:154-155.
35. Shoenfeld Y, Lev S, Blatt I, et al. Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol. 2004;31:1344-1348.
36. Krause I, Lev S, Fraser A, et al. Close association between valvular heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis. 2005:1-11.
37. Kumral E, Evyapan D, Keser G, et al. Detection of microemboli signals in patients with neuropsychiatric lupus erythematosus. Eur Neurol. 2002;47:131-135.
38. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol. 1988;23:380-384.